Results of a pharmacoeconomic analysis of the rationality of the use of acute myeloid leukemia chemotherapy regimens with the use of various doses of cytarabine
BIO Web Conf., 30 (2021) 03003
Published online: 22 April 2021
DOI: 10.1051/bioconf/20213003003